US 10323085
Methods of treating fibromyalgia
granted A61KA61K2039/505A61K39/3955
Quick answer
US patent 10323085 (Methods of treating fibromyalgia) held by TEVA PHARMACEUTICALS INTERNATIONAL GMBH expires Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICALS INTERNATIONAL GMBH
- Grant date
- Tue Jun 18 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K2039/505, A61K39/3955, A61K45/06, A61P